Bei Y. He

FDA investigator

Appears on 14 documents from 2016 to 2025, most often at sites in Michigan. Most often cites control of microbiological contamination (21 CFR 211.113).

14
Documents on file
6.4
Observations per 483
2016
First seen
2025
Most recent

What they cite most

From 99 observations

Activity by year

2016: 2, 2017: 2, 2018: 2, 2019: 4, 2020: 1, 2021: 1, 2025: 2

Where

Michigan 5 · Canada 2 · Indiana 2 · Alabama 1 · Florida 1 · Illinois 1

Is Bei Y. He coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

14 documents, newest first
FirmOpen
483 F.H. Investments, Inc. (dba Asteria Health)Dec 19, 2025 · Birmingham, Alabama
483 GenoGeni xJul 18, 2025 · Boca Raton, Florida
483 Grand River Aseptic Manufacturing, Inc.Jul 2, 2021 · Grand Rapids, Michigan
483 Advanced Nutriceuticals, LLCOct 29, 2020 · Indianapolis, Indiana
483 Nesher Pharmaceuticals (USA) LLCJul 31, 2019 · Bridgeton, Missouri
483 Novocol Pharmaceutical of Canada, Inc.Jun 18, 2019 · Cambridge, Canada
483 Innocore Sales & Marketing IncJun 6, 2019 · Woodstock, Canada

About this profile

What does Bei Y. He inspect?

Bei Y. He appears on 14 documents on file covering 14 sites, most often in Michigan.

What do they cite most often?

21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.42 and 21 CFR 211.22.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Bei Y. He is dated Dec 19, 2025.

FDA Investigator Bei Y. He: 483s & Inspections · FDA Intel